Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer
Journal of Nuclear Medicine · 2025
DOI: 10.2967/jnumed.124.268499 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Pierre Vera und 37 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine, QuantIF-LITIS (EA4108), Centre Henri Becquerel, Rouen, France; pierre.vera@chb.unicancer.fr. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Chemoradiotherapy, Fluorodeoxyglucose F18, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Medicine, QuantIF-LITIS (EA4108), Centre Henri Becquerel, Rouen, France; pierre.vera@chb.unicancer.fr.
- Radiotherapy, Université Paris Cité, European Hospital Georges-Pompidou, AP-HP, Paris, France.
- Nuclear Medicine, Centre Henri Becquerel, Rouen, France.
- Clinical Research, IFCT, Paris, France.
- Clinical Research, Centre Henri Becquerel, Rouen, France.
- Radiotherapy, Centre Oscar Lambret, Lille, France.
Zitieren
APA
Vera, P., Giraud, P., Hapdey, S., Gouel, P., Jan, O., Le Roux, P., Langlais, A., Lévêque, E., Le Tinier, F., Olivier, A., Martin, E., Berriolo-Riedinger, A., Pourel, N., Broglia, J. M., Boisselier, P., Guillemard, S., Salem, N., Brenot-Rossi, I., Garcia, C., …, & Thureau, S. (2025). Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.268499
Vancouver
Vera P, Giraud P, Hapdey S, Gouel P, Jan O, Le Roux P, et al. Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.124.268499
BibTeX
@article{Vera2025,
author = {Vera, Pierre and Giraud, Philippe and Hapdey, Sébastien and Gouel, Pierrick and Jan, Orianne and Le Roux, Paul and Langlais, Alexandra and Lévêque, Emilie and Le Tinier, Florence and Olivier, Anaïs and Martin, Etienne and Berriolo-Riedinger, Alina and Pourel, Nicolas and Broglia, Jean Marc and Boisselier, Pierre and Guillemard, Sophie and Salem, Naji and Brenot-Rossi, Isabelle and Garcia, Camilo and Berthold, Céline and Giroux-Leprieur, Etienne and Moreau, Damien and Guillerm, Sophie and Benali, Khadija and Tessonnier, Laurent and Audigier-Valette, Clarisse and Lerouge, Delphine and Quak, Elske and Massabeau, Carole and Courbon, Frédéric and Loo, Maxime and Larrouy, Anne and Ghazzar, Nadia and Chaumet-Riffaud, Philippe and Amour, Elodie and Zalcman, Gérard and Modzelewski, Romain and Thureau, Sébastien},
title = {Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer},
journal = {Journal of Nuclear Medicine},
year = {2025},
doi = {10.2967/jnumed.124.268499}
}
EUVIMED